Rud Bo, Vejborg Thomas S, Rappeport Eli D, Reitsma Johannes B, Wille-Jørgensen Peer
Copenhagen University Hospital Hvidovre, Gastrounit, Surgical Division, Kettegaards Alle 30, Hvidovre, Denmark, 2650.
Bispebjerg Hospital, University of Copenhagen, Department of Radiology R, 23 Bispebjerg Bakke, Copenhagen, Denmark, DK 2400 NV.
Cochrane Database Syst Rev. 2019 Nov 19;2019(11):CD009977. doi: 10.1002/14651858.CD009977.pub2.
Diagnosing acute appendicitis (appendicitis) based on clinical evaluation, blood testing, and urinalysis can be difficult. Therefore, in persons with suspected appendicitis, abdominopelvic computed tomography (CT) is often used as an add-on test following the initial evaluation to reduce remaining diagnostic uncertainty. The aim of using CT is to assist the clinician in discriminating between persons who need surgery with appendicectomy and persons who do not.
Primary objective Our primary objective was to evaluate the accuracy of CT for diagnosing appendicitis in adults with suspected appendicitis. Secondary objectives Our secondary objectives were to compare the accuracy of contrast-enhanced versus non-contrast-enhanced CT, to compare the accuracy of low-dose versus standard-dose CT, and to explore the influence of CT-scanner generation, radiologist experience, degree of clinical suspicion of appendicitis, and aspects of methodological quality on diagnostic accuracy.
We searched MEDLINE, Embase, and Science Citation Index until 16 June 2017. We also searched references lists. We did not exclude studies on the basis of language or publication status.
We included prospective studies that compared results of CT versus outcomes of a reference standard in adults (> 14 years of age) with suspected appendicitis. We excluded studies recruiting only pregnant women; studies in persons with abdominal pain at any location and with no particular suspicion of appendicitis; studies in which all participants had undergone ultrasonography (US) before CT and the decision to perform CT depended on the US outcome; studies using a case-control design; studies with fewer than 10 participants; and studies that did not report the numbers of true-positives, false-positives, false-negatives, and true-negatives. Two review authors independently screened and selected studies for inclusion.
Two review authors independently collected the data from each study and evaluated methodological quality according to the Quality Assessment of Studies of Diagnostic Accuracy - Revised (QUADAS-2) tool. We used the bivariate random-effects model to obtain summary estimates of sensitivity and specificity.
We identified 64 studies including 71 separate study populations with a total of 10,280 participants (4583 with and 5697 without acute appendicitis). Estimates of sensitivity ranged from 0.72 to 1.0 and estimates of specificity ranged from 0.5 to 1.0 across the 71 study populations. Summary sensitivity was 0.95 (95% confidence interval (CI) 0.93 to 0.96), and summary specificity was 0.94 (95% CI 0.92 to 0.95). At the median prevalence of appendicitis (0.43), the probability of having appendicitis following a positive CT result was 0.92 (95% CI 0.90 to 0.94), and the probability of having appendicitis following a negative CT result was 0.04 (95% CI 0.03 to 0.05). In subgroup analyses according to contrast enhancement, summary sensitivity was higher for CT with intravenous contrast (0.96, 95% CI 0.92 to 0.98), CT with rectal contrast (0.97, 95% CI 0.93 to 0.99), and CT with intravenous and oral contrast enhancement (0.96, 95% CI 0.93 to 0.98) than for unenhanced CT (0.91, 95% CI 0.87 to 0.93). Summary sensitivity of CT with oral contrast enhancement (0.89, 95% CI 0.81 to 0.94) and unenhanced CT was similar. Results show practically no differences in summary specificity, which varied from 0.93 (95% CI 0.90 to 0.95) to 0.95 (95% CI 0.90 to 0.98) between subgroups. Summary sensitivity for low-dose CT (0.94, 95% 0.90 to 0.97) was similar to summary sensitivity for standard-dose or unspecified-dose CT (0.95, 95% 0.93 to 0.96); summary specificity did not differ between low-dose and standard-dose or unspecified-dose CT. No studies had high methodological quality as evaluated by the QUADAS-2 tool. Major methodological problems were poor reference standards and partial verification primarily due to inadequate and incomplete follow-up in persons who did not have surgery.
AUTHORS' CONCLUSIONS: The sensitivity and specificity of CT for diagnosing appendicitis in adults are high. Unenhanced standard-dose CT appears to have lower sensitivity than standard-dose CT with intravenous, rectal, or oral and intravenous contrast enhancement. Use of different types of contrast enhancement or no enhancement does not appear to affect specificity. Differences in sensitivity and specificity between low-dose and standard-dose CT appear to be negligible. The results of this review should be interpreted with caution for two reasons. First, these results are based on studies of low methodological quality. Second, the comparisons between types of contrast enhancement and radiation dose may be unreliable because they are based on indirect comparisons that may be confounded by other factors.
基于临床评估、血液检测和尿液分析来诊断急性阑尾炎可能具有挑战性。因此,对于疑似阑尾炎的患者,腹部盆腔计算机断层扫描(CT)通常在初始评估后用作附加检查,以减少剩余的诊断不确定性。使用CT的目的是帮助临床医生区分需要进行阑尾切除术的患者和不需要手术的患者。
主要目的 我们的主要目的是评估CT在诊断疑似阑尾炎成人患者中阑尾炎的准确性。次要目的 我们的次要目的是比较增强CT与非增强CT的准确性,比较低剂量CT与标准剂量CT的准确性,并探讨CT扫描仪类型、放射科医生经验、阑尾炎临床怀疑程度以及方法学质量方面对诊断准确性的影响。
我们检索了MEDLINE数据库、Embase数据库和科学引文索引,检索截止至2017年6月16日。我们还检索了参考文献列表。我们没有基于语言或发表状态排除研究。
我们纳入了前瞻性研究,这些研究比较了CT结果与参考标准在年龄大于14岁的疑似阑尾炎成人患者中的结果。我们排除了仅招募孕妇的研究;对任何部位腹痛且无阑尾炎特别怀疑的患者的研究;所有参与者在CT检查前均接受过超声检查(US)且进行CT检查的决定取决于US结果的研究;采用病例对照设计的研究;参与者少于10人的研究;以及未报告真阳性、假阳性、假阴性和真阴性数量的研究。两名综述作者独立筛选并选择纳入研究。
两名综述作者独立从每项研究中收集数据,并根据诊断准确性研究质量评估修订版(QUADAS - 2)工具评估方法学质量。我们使用双变量随机效应模型来获得敏感性和特异性的汇总估计值。
我们确定了64项研究,包括71个独立的研究人群,共有10280名参与者(4583名患有急性阑尾炎,5697名未患急性阑尾炎)。在71个研究人群中,敏感性估计范围为0.72至1.0,特异性估计范围为0.5至1.0。汇总敏感性为0.95(95%置信区间(CI)0.93至0.96),汇总特异性为0.94(95%CI 0.92至0.95)。在阑尾炎的中位患病率(0.43)下,CT结果为阳性时患阑尾炎的概率为0.92(95%CI 0.90至0.94),CT结果为阴性时患阑尾炎的概率为0.04(95%CI 0.03至0.05)。在根据增强方式进行的亚组分析中,静脉注射造影剂的CT(0.96,95%CI 0.92至0.98)、直肠造影剂CT(0.97,95%CI 0.93至0.99)以及静脉和口服造影剂增强CT(0.96,95%CI 0.93至0.98)的汇总敏感性高于未增强CT(0.91,95%CI 0.87至0.93)。口服造影剂增强CT(0.8�,95%CI 0.81至0.94)和未增强CT的汇总敏感性相似。结果显示汇总特异性实际上没有差异,亚组之间从0.93(95%CI 0.90至0.95)到0.95(95%CI 0.90至0.98)不等。低剂量CT(0.94,95% 0.90至0.97)的汇总敏感性与标准剂量或未指定剂量CT(0.95,95% 0.93至0.96)的汇总敏感性相似;低剂量CT与标准剂量或未指定剂量CT之间的汇总特异性没有差异。根据QUADAS - 2工具评估,没有研究具有高方法学质量。主要的方法学问题是参考标准不佳和部分验证,主要是由于未进行手术的患者随访不足和不完整。
CT在诊断成人阑尾炎中的敏感性和特异性较高。未增强的标准剂量CT似乎比静脉注射、直肠或口服及静脉注射造影剂增强的标准剂量CT敏感性低。使用不同类型的造影剂增强或不增强似乎不影响特异性。低剂量CT与标准剂量CT之间敏感性和特异性的差异似乎可以忽略不计。由于两个原因,本综述的结果应谨慎解释。首先,这些结果基于方法学质量较低的研究。其次,造影剂增强类型和辐射剂量之间的比较可能不可靠,因为它们基于可能被其他因素混淆的间接比较。